VSee Health, Inc.
VSEE
$0.24
$0.001.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.13% | 18.67% | 98.07% | 104.90% | 161.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.13% | 18.67% | 98.07% | 104.90% | 161.53% |
| Cost of Revenue | 54.57% | 234.81% | 92.77% | 278.33% | 233.96% |
| Gross Profit | -22.97% | -25.55% | 104.44% | 50.64% | 132.82% |
| SG&A Expenses | -0.99% | 4.61% | 122.16% | 234.27% | 293.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.27% | 33.64% | 133.67% | 245.69% | 279.84% |
| Operating Income | -16.78% | -76.76% | -220.18% | -1,504.37% | -790.83% |
| Income Before Tax | -145.17% | 99.46% | -11.27% | -4,262.34% | -917.07% |
| Income Tax Expenses | 88.76% | -- | 100.27% | -- | -98.90% |
| Earnings from Continuing Operations | -144.71% | 99.46% | -292.33% | -4,276.58% | -16.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -144.71% | 99.46% | -312.13% | -6,404.78% | -15.57% |
| EBIT | -16.78% | -76.76% | -220.18% | -1,504.37% | -790.83% |
| EBITDA | -22.87% | -174.26% | -128.70% | -1,004.05% | -588.28% |
| EPS Basic | -23.54% | 99.51% | -33.03% | -1,897.78% | 26.84% |
| Normalized Basic EPS | -26.26% | -106.81% | 61.18% | -1,708.51% | -331.69% |
| EPS Diluted | -23.54% | 99.51% | -33.03% | -2,527.00% | 26.84% |
| Normalized Diluted EPS | -26.26% | -106.81% | 61.18% | -1,708.51% | -331.69% |
| Average Basic Shares Outstanding | 98.03% | 9.76% | 209.72% | 251.59% | 58.01% |
| Average Diluted Shares Outstanding | 98.03% | 9.76% | 209.72% | 251.59% | 58.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |